A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Impact of Astroprincin (FAM171A1) Expression in Oral Tongue Cancer




TekijätWahab Awais, Almangush Alhadi, Andersson Leif C, Nieminen Pentti, Salo Tuula

KustantajaFrontiers Media SA

Julkaisuvuosi2020

JournalFrontiers in Oral Health

Tietokannassa oleva lehden nimiFrontiers in oral health

Lehden akronyymiFront Oral Health

Vuosikerta1

ISSN2673-4842

eISSN2673-4842

DOIhttps://doi.org/10.3389/froh.2020.599421

Verkko-osoitehttps://www.frontiersin.org/articles/10.3389/froh.2020.599421/full

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/69071839


Tiivistelmä
Astroprincin (APCN, FAM171A1) is a recently characterized transmembrane glycoprotein that is abundant in brain astrocytes and is overexpressed in some tumors. However, the expression and role of APCN is unknown in oral tongue squamous cell carcinoma (OTSCC). Aim of this study was to investigate the expression of APCN in OTSCC tissue samples and to analyze possible association of APCN with clinicopathological features and survival rates. This study included 76 patients treated for OTSCC. Expression of APCN in OTSCC tissue sections was examined by immunohistochemistry with a rabbit polyclonal antibody (MAP346) against APCN. All tumors were scored for intensity and percentage of APCN staining at the superficial, middle, and invasive front areas. High expression of APCN was significantly associated with increased tumor size (P = 0.013) and with OTSCC recurrence (P = 0.026). In this pilot study, we observed that the amount of APCN is associated with the size and recurrence of OTSCC. This finding suggests a role of APCN during OTSCC progression.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 11:33